This webinar will be hosted live and available on-demand Wednesday, February 28, 2024 11:00 AM-12:00 PM Eastern Time (8:00 AM PT and 5:00 PM CET) As the demands and requirements for new antibodies continue to evolve, access to broader antibody sequence diversity coupled with a powerful screening technology is critical. Unlike hybridoma and display technologies …
Cellular Analysis Blog
Explore Events Articles
Latest
Explore Cutting-Edge Antibody Discovery with Bruker Cellular Analysis at the Antibody Engineering & Therapeutics Conference
We’re excited to announce that from December 13-16, Bruker Cellular Analysis will be an exhibitor at this year’s Antibody Engineering & Therapeutics Conference in San Diego. This premier event is dedicated to showcasing the latest advancements in antibody engineering, design, and selection. With a focus on diverse topics such as Neurodegenerative Diseases, Tumor Microenvironment in …
Unveiling the Future of Protein and Antibody Research: The PEGS International Conference
The Protein & Antibody Engineering Summit (PEGS) International Conference, set to take place from November 14-16th at the Lisbon Congress Center in Lisbon, Portugal, is the largest protein & antibody engineering event in Europe, which has been described as “the best biologics technology meeting in Europe.” The team from Bruker Cellular Analysis will be at …
Unveiling the Future of Protein and Antibody Research: The PEGS International Conference Read More »
SITC SPOTLIGHT: Visit us at Booth 432 to Learn How Our Platforms are Addressing the Challenges of Developing Advanced Therapies
Bruker Cellular Analysis will be participating in the upcoming Society for Immunotherapy of Cancer (SITC) Conference, scheduled to take place on November 1-5 at the San Diego Convention Center. This conference stands as a leading global event that unites experts from the field of immunotherapy to advance the science, discover breakthroughs, and educate the world …
Upcoming Webinar: How to Speed Up Cell Therapy Development Processes
Although cellular immunotherapy can achieve good outcomes, only a small proportion of cancer patients are being treated via this approach, with extremely long waitlists. Furthermore, applying centralized manufacturing workflows to individualized products results in complex logistics, creating laborious and non-standardized processes that elevate drug costs. In this upcoming webinar on Thursday, October 26, 10:00-11:00 AM …
Upcoming Webinar: How to Speed Up Cell Therapy Development Processes Read More »
Upcoming Webinar: Accelerating Antibody Discovery for Difficult Targets
Scientists often use classical immunization strategies and hybridoma technologies to generate antibodies. However, when producing antibodies against poorly immunogenic targets, such as membrane proteins with short extracellular domains, these approaches achieve limited antibody diversity, making it difficult for scientists to select good candidates for pharmaceutical development. Innovative approaches that combine RNA immunization and single cell …
Upcoming Webinar: Accelerating Antibody Discovery for Difficult Targets Read More »
Unleashing the Future of Functional Cell Biology: Bruker Cellular Analysis to Attend Two Major Conferences
In the dynamic world of science and technology, Bruker Cellular Analysis is at the forefront, driving advancements in functional cell biology to improve human health. Our goal is to empower scientists to maximize the potential of every cell through pioneering optofluidic and proteomic technologies. We are excited to share our latest innovations and collaborations at …
Upcoming Webinar 9/14/23: Enhance and Expand Anti-ID Antibody Diversity and Affinity Through Genetic Immunization
Biotherapeutics comprise a large portion of the treatment options for a wide range of conditions and account for almost half of drugs approvals in 2022. However, the pace of new biologic development has not grown in recent years in part because of the increasing complexity of drug targets and desired performance of these drugs. To …
Advancing Cancer Immunotherapy with Optofluidics and Proteomic Barcoding Technologies
The convergence of optofluidics and proteomic barcoding technologies marks a significant milestone in the evolution of cancer immunotherapy research. These cutting-edge tools empower scientists to unravel the complexities of immune responses, cellular behaviors, and functional proteomics with unprecedented speed and precision. As the pursuit of personalized medicine gains momentum, these technologies offer promise in guiding …
Advancing Cancer Immunotherapy with Optofluidics and Proteomic Barcoding Technologies Read More »
Upcoming Webinar 9/11/23: Harnessing the Power of Single Cell Technologies to Identify Biologically Relevant Parameters Associated with Favorable T Cell-Mediated Antitumor Responses
In both research and clinical settings, the ability to identify which immune cells in a person’s body contribute to either cancer progression or clearance and their target specificity is of critical importance. Moreover, a more thorough understanding of the biological properties of T cells that correlate with clinical outcome is required and can help guide …
Unlock the Phenome